Australia markets closed

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
177.37+0.25 (+0.14%)
At close: 04:00PM EDT
177.37 0.00 (0.00%)
After hours: 05:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.10B
Enterprise value 4.93B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.16
Price/book (mrq)22.46
Enterprise value/revenue 16.40
Enterprise value/EBITDA -123.03

Trading information

Stock price history

Beta (5Y monthly) 1.56
52-week change 3-25.89%
S&P500 52-week change 3-16.45%
52-week high 3286.29
52-week low 3142.74
50-day moving average 3202.11
200-day moving average 3210.62

Share statistics

Avg vol (3-month) 3259.57k
Avg vol (10-day) 3298.57k
Shares outstanding 528.79M
Implied shares outstanding 6N/A
Float 827.21M
% held by insiders 11.94%
% held by institutions 197.89%
Shares short (30 Aug 2022) 41.34M
Short ratio (30 Aug 2022) 44.7
Short % of float (30 Aug 2022) 44.76%
Short % of shares outstanding (30 Aug 2022) 44.66%
Shares short (prior month 28 July 2022) 41.41M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin -14.60%
Operating margin (ttm)-13.85%

Management effectiveness

Return on assets (ttm)-9.23%
Return on equity (ttm)-19.66%

Income statement

Revenue (ttm)300.85M
Revenue per share (ttm)10.96
Quarterly revenue growth (yoy)72.60%
Gross profit (ttm)200.12M
EBITDA -40.22M
Net income avi to common (ttm)-43.92M
Diluted EPS (ttm)-1.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)196.32M
Total cash per share (mrq)7.1
Total debt (mrq)31.34M
Total debt/equity (mrq)13.81
Current ratio (mrq)5.62
Book value per share (mrq)8.21

Cash flow statement

Operating cash flow (ttm)-18.31M
Levered free cash flow (ttm)-6.36M